GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE

GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE was reported 7317 times

GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 11 0.0296
1 POST-TUSSIVE VOMITING 3 0.0184
2 PRODUCT SIZE ISSUE 92 0.0171
3 ACCIDENTAL OVERDOSE 543 0.0148
4 LOOP ELECTROSURGICAL EXCISION PROCEDURE 2 0.0141
5 CENTRAL NERVOUS SYSTEM STIMULATION 2 0.0113
6 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0111
7 ILLOGICAL THINKING 2 0.0106
8 INCORRECT PRODUCT ADMINISTRATION DURATION 222 0.0102
9 FOREIGN BODY IN RESPIRATORY TRACT 12 0.0091
10 COLD URTICARIA 2 0.0091
11 ORAL CONTUSION 2 0.0087
12 NEUROGENIC BOWEL 2 0.0084
13 PHARYNGITIS BACTERIAL 2 0.0078
14 FOREIGN BODY IN THROAT 22 0.0070
15 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 182 0.0062
16 BRAIN MASS 2 0.0059
17 ACQUIRED DIAPHRAGMATIC EVENTRATION 2 0.0056
18 AUTOSCOPY 3 0.0056
19 INCORRECT DRUG ADMINISTRATION DURATION 155 0.0055
20 INJECTION SITE PUSTULE 2 0.0052
21 EXPIRED PRODUCT ADMINISTERED 170 0.0051
22 CHRONIC HEPATITIS C 2 0.0051
23 PRODUCT USED FOR UNKNOWN INDICATION 6 0.0048
24 CHOKING SENSATION 26 0.0047
25 APPARENT LIFE THREATENING EVENT 2 0.0047
26 ALLERGY TO ARTHROPOD STING 2 0.0044
27 BIOPSY BONE MARROW 2 0.0043
28 PRODUCT USE COMPLAINT 65 0.0041
29 BLADDER MASS 2 0.0040
30 EUPHORIC MOOD 40 0.0039
31 BLOOD IMMUNOGLOBULIN A INCREASED 2 0.0037
32 MORNING SICKNESS 2 0.0037
33 NAIL BED BLEEDING 2 0.0035
34 HEAD BANGING 2 0.0035
35 FEELING DRUNK 26 0.0035
36 DEVICE MAINTENANCE ISSUE 2 0.0034
37 BRONCHIAL HYPERREACTIVITY 4 0.0033
38 CONTRAINDICATION TO MEDICAL TREATMENT 5 0.0033
39 INAPPROPRIATE AFFECT 5 0.0032
40 PRODUCT AFTER TASTE 3 0.0031
41 BLADDER IRRITATION 2 0.0031
42 INFUSION SITE INFLAMMATION 2 0.0028
43 INFUSION SITE MASS 3 0.0028
44 PHIMOSIS 2 0.0027
45 AMPHETAMINES POSITIVE 2 0.0027
46 DIZZINESS EXERTIONAL 2 0.0026
47 CAUDA EQUINA SYNDROME 2 0.0026
48 OXYGEN CONSUMPTION INCREASED 6 0.0025
49 INTERVERTEBRAL DISC SPACE NARROWING 2 0.0025
50 NASAL DRYNESS 15 0.0024
51 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE III 2 0.0024
52 ENZYME LEVEL INCREASED 2 0.0024
53 LEFT ATRIAL DILATATION 3 0.0024
54 INFUSION SITE IRRITATION 3 0.0023
55 ALLERGIC SINUSITIS 2 0.0023
56 TERMINAL INSOMNIA 4 0.0023
57 FEELING JITTERY 43 0.0023
58 EXPIRED DRUG ADMINISTERED 11 0.0022
59 URETERIC OBSTRUCTION 3 0.0022
60 ESSENTIAL HYPERTENSION 4 0.0022
61 THERAPEUTIC PROCEDURE 3 0.0021
62 DYSPNOEA AT REST 6 0.0021
63 HYPERVIGILANCE 2 0.0021
64 NASAL SEPTUM DEVIATION 4 0.0020
65 TACHYPHRENIA 7 0.0020
66 MENTAL FATIGUE 3 0.0020
67 HYPOSMIA 3 0.0020
68 RETCHING 42 0.0020
69 MYDRIASIS 25 0.0019
70 CORONAVIRUS TEST POSITIVE 2 0.0019
71 LIGHT CHAIN ANALYSIS INCREASED 2 0.0019
72 AMAUROSIS FUGAX 2 0.0019
73 KIDNEY ENLARGEMENT 2 0.0018
74 ILLUSION 3 0.0018
75 MIDDLE EAR EFFUSION 4 0.0018
76 OVERDOSE 390 0.0018
77 GASTROINTESTINAL ULCER HAEMORRHAGE 2 0.0018
78 BILIARY DYSKINESIA 3 0.0018
79 DIZZINESS 863 0.0017
80 MUCOSAL HAEMORRHAGE 2 0.0017
81 PAROTITIS 2 0.0017
82 OTORRHOEA 3 0.0017
83 INFUSION SITE DISCHARGE 3 0.0017
84 MORBID THOUGHTS 2 0.0017
85 URINE ODOUR ABNORMAL 10 0.0017
86 RESPIRATORY TRACT CONGESTION 27 0.0017
87 PHYSICAL PRODUCT LABEL ISSUE 2 0.0017
88 FULL BLOOD COUNT INCREASED 2 0.0017
89 DRY THROAT 17 0.0017
90 LIP DISORDER 3 0.0016
91 BRONCHIAL SECRETION RETENTION 2 0.0016
92 HYPOREFLEXIA 3 0.0016
93 THERAPEUTIC PRODUCT INEFFECTIVE 6 0.0016
94 ABDOMINAL OPERATION 2 0.0015
95 PRODUCT COMPLAINT 39 0.0015
96 CHOKING 30 0.0015
97 HALLUCINATION 114 0.0015
98 LIP EXFOLIATION 2 0.0015
99 SOMNOLENCE 300 0.0015
100 MUCOSAL DRYNESS 3 0.0015
101 SEASONAL ALLERGY 21 0.0015
102 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 10 0.0015
103 CARBON DIOXIDE INCREASED 2 0.0015
104 CLUSTER HEADACHE 2 0.0015
105 INFUSION SITE RASH 2 0.0015
106 INTERNATIONAL NORMALISED RATIO ABNORMAL 5 0.0015
107 ANOSMIA 21 0.0014
108 PRODUCT USE IN UNAPPROVED INDICATION 358 0.0014
109 DISORIENTATION 57 0.0014
110 HAEMOPTYSIS 40 0.0014
111 CATAPLEXY 2 0.0014
112 APPARENT DEATH 5 0.0014
113 BONE LESION 5 0.0014
114 AGEUSIA 34 0.0014
115 COCCYDYNIA 2 0.0014
116 UPPER-AIRWAY COUGH SYNDROME 11 0.0013
117 SNORING 5 0.0013
118 ORAL MUCOSAL EXFOLIATION 2 0.0013
119 PARANASAL SINUS DISCOMFORT 5 0.0013
120 NERVOUSNESS 69 0.0013
121 ORAL PRURITUS 3 0.0013
122 CALCULUS URINARY 2 0.0013
123 NECK SURGERY 3 0.0013
124 EPIGASTRIC DISCOMFORT 5 0.0013
125 OSTEOSCLEROSIS 2 0.0013
126 ENURESIS 5 0.0012
127 HAEMATOLOGICAL INFECTION 3 0.0012
128 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 67 0.0012
129 INFUSION SITE HAEMORRHAGE 4 0.0012
130 FEELING ABNORMAL 291 0.0012
131 PULMONARY CONGESTION 16 0.0012
132 ARTHROPOD STING 2 0.0012
133 DISEASE RECURRENCE 57 0.0012
134 HYPOAESTHESIA ORAL 18 0.0012
135 EXCORIATION 3 0.0012
136 PRODUCT LABEL ISSUE 8 0.0012
137 INCREASED BRONCHIAL SECRETION 3 0.0012
138 CERVICAL SPINAL STENOSIS 2 0.0012
139 ACUTE SINUSITIS 2 0.0012
140 PRESYNCOPE 28 0.0012
141 MULTIPLE ALLERGIES 9 0.0011
142 APHONIA 16 0.0011
143 PSYCHOMOTOR HYPERACTIVITY 19 0.0011
144 BLOOD PRESSURE INCREASED 174 0.0011
145 CATHETERISATION CARDIAC 5 0.0011
146 EPISTAXIS 84 0.0011
147 SECRETION DISCHARGE 14 0.0011
148 BREAST SWELLING 3 0.0011
149 PRODUCTIVE COUGH 53 0.0011
150 PLEURITIC PAIN 3 0.0011
151 BODY TEMPERATURE ABNORMAL 2 0.0011
152 PALPITATIONS 127 0.0011
153 CARDIAC FLUTTER 7 0.0011
154 COLD SWEAT 19 0.0011
155 HEAD DISCOMFORT 19 0.0011
156 INFECTED SKIN ULCER 2 0.0011
157 EYE DISCHARGE 11 0.0011
158 MYELOPATHY 2 0.0011
159 PARANASAL SINUS HYPERSECRETION 4 0.0010
160 GASTRIC INFECTION 4 0.0010
161 CONVERSION DISORDER 2 0.0010
162 HEART RATE INCREASED 102 0.0010
163 BRAIN FOG 16 0.0010
164 HYPOGEUSIA 2 0.0010
165 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
166 BREATH SOUNDS ABNORMAL 5 0.0010
167 INSOMNIA 268 0.0010
168 ANAL INCONTINENCE 9 0.0010
169 DIARRHOEA 640 0.0010
170 EMPHYSEMA 10 0.0010
171 RESTLESSNESS 36 0.0010
172 INITIAL INSOMNIA 10 0.0010
173 DIVERTICULAR PERFORATION 2 0.0010
174 FAECES DISCOLOURED 21 0.0010
175 ANAL PRURITUS 2 0.0010
176 SINUS CONGESTION 13 0.0010
177 SINUS DISORDER 19 0.0010
178 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 193 0.0010
179 NEUROGENIC BLADDER 2 0.0009
180 PNEUMONIA VIRAL 3 0.0009
181 THROAT IRRITATION 42 0.0009
182 CATHETER SITE ERYTHEMA 2 0.0009
183 EXPOSED BONE IN JAW 2 0.0009
184 OEDEMA MOUTH 3 0.0009
185 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 164 0.0009
186 ASTHENOPIA 5 0.0009
187 NEAR DEATH EXPERIENCE 3 0.0009
188 DIABETIC NEPHROPATHY 2 0.0009
189 HALLUCINATION, VISUAL 19 0.0009
190 SLEEP APNOEA SYNDROME 17 0.0009
191 URINE ABNORMALITY 4 0.0009
192 THERAPEUTIC PRODUCT EFFECT DELAYED 4 0.0009
193 EAR DISCOMFORT 9 0.0009
194 PNEUMONIA BACTERIAL 8 0.0009
195 LIP SWELLING 29 0.0009
196 VIITH NERVE PARALYSIS 3 0.0009
197 INFUSION SITE INFECTION 2 0.0009
198 INFUSION SITE PAIN 11 0.0009
199 HANGOVER 3 0.0009
200 ENERGY INCREASED 5 0.0008
201 GLOSSITIS 3 0.0008
202 RESPIRATORY TRACT INFECTION 22 0.0008
203 SPUTUM DISCOLOURED 8 0.0008
204 BRONCHITIS 62 0.0008
205 FACIAL BONES FRACTURE 3 0.0008
206 INFUSION SITE ERYTHEMA 7 0.0008
207 DRY MOUTH 67 0.0008
208 PANIC ATTACK 30 0.0008
209 COUGH 228 0.0008
210 DEVICE INFUSION ISSUE 2 0.0008
211 NO ADVERSE EVENT 146 0.0008
212 INFUSION SITE EXTRAVASATION 5 0.0008
213 PRE-EXISTING CONDITION IMPROVED 5 0.0008
214 CATHETER SITE HAEMORRHAGE 2 0.0008
215 CHRONIC SINUSITIS 3 0.0008
216 FACE INJURY 3 0.0008
217 POOR QUALITY SLEEP 17 0.0008
218 HOSTILITY 2 0.0008
219 ABDOMINAL PAIN UPPER 162 0.0008
220 LACTOSE INTOLERANCE 2 0.0008
221 INCREASED UPPER AIRWAY SECRETION 4 0.0008
222 OROPHARYNGEAL DISCOMFORT 7 0.0008
223 CATHETER SITE PAIN 2 0.0008
224 HERNIA REPAIR 2 0.0008
225 CONFUSIONAL STATE 124 0.0008
226 PARAESTHESIA ORAL 11 0.0008
227 DYSURIA 28 0.0008
228 ANIMAL BITE 2 0.0007
229 DRUG INEFFECTIVE 989 0.0007
230 FOOD POISONING 4 0.0007
231 ABDOMINAL MASS 2 0.0007
232 INTERNATIONAL NORMALISED RATIO DECREASED 3 0.0007
233 LIP BLISTER 2 0.0007
234 HICCUPS 6 0.0007
235 ONYCHOCLASIS 5 0.0007
236 LYMPHOEDEMA 5 0.0007
237 SINUSITIS 74 0.0007
238 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 51 0.0007
239 HALLUCINATIONS, MIXED 3 0.0007
240 BURNING SENSATION 50 0.0007
241 DELUSION 11 0.0007
242 NECK MASS 2 0.0007
243 HEPATIC PAIN 3 0.0007
244 PURULENT DISCHARGE 3 0.0007
245 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0007
246 LOSS OF CONSCIOUSNESS 89 0.0007
247 FIBULA FRACTURE 2 0.0007
248 PRURITUS GENERALISED 15 0.0007
249 PARAPLEGIA 2 0.0007
250 PANIC REACTION 5 0.0007
251 TONGUE DISCOLOURATION 3 0.0007
252 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
253 DYSPHEMIA 3 0.0007
254 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
255 DECREASED INTEREST 4 0.0007
256 FACIAL PAIN 6 0.0007
257 THIRST 12 0.0007
258 ODYNOPHAGIA 4 0.0007
259 GASTROINTESTINAL INFECTION 6 0.0007
260 FEELING HOT 41 0.0007
261 ATYPICAL PNEUMONIA 2 0.0007
262 HYDRONEPHROSIS 5 0.0007
263 SCRATCH 7 0.0007
264 TOOTHACHE 12 0.0007
265 CRANIOCEREBRAL INJURY 2 0.0007
266 DRUG ABUSE 55 0.0007
267 IRITIS 2 0.0007
268 ABDOMINAL HERNIA 3 0.0007
269 ABDOMINAL DISCOMFORT 110 0.0007
270 DIABETIC FOOT 2 0.0007
271 MASTICATION DISORDER 2 0.0007
272 PHARYNGEAL OEDEMA 10 0.0006
273 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
274 IRON DEFICIENCY ANAEMIA 6 0.0006
275 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
276 NAUSEA 513 0.0006
277 OROPHARYNGEAL PAIN 60 0.0006
278 MUSCULOSKELETAL CHEST PAIN 10 0.0006
279 WHEEZING 38 0.0006
280 BLOOD BLISTER 2 0.0006
281 SPINAL COLUMN STENOSIS 3 0.0006
282 BREAST CANCER RECURRENT 2 0.0006
283 BLOOD URINE PRESENT 12 0.0006
284 NASAL CONGESTION 37 0.0006
285 HYPERHIDROSIS 81 0.0006
286 MEDICATION RESIDUE PRESENT 3 0.0006
287 ILLNESS 64 0.0006
288 ENTEROCOCCAL INFECTION 3 0.0006
289 DIZZINESS POSTURAL 6 0.0006
290 DYSSTASIA 18 0.0006
291 ANXIETY 175 0.0006
292 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
293 PHARYNGEAL SWELLING 6 0.0006
294 MICTURITION URGENCY 7 0.0006
295 VOMITING 288 0.0006
296 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
297 UNEVALUABLE EVENT 46 0.0006
298 DIABETIC NEUROPATHY 3 0.0006
299 APPETITE DISORDER 4 0.0006
300 RHINORRHOEA 39 0.0006
301 PEPTIC ULCER 2 0.0006
302 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
303 POST-TRAUMATIC STRESS DISORDER 4 0.0006
304 CHEST DISCOMFORT 61 0.0006
305 METASTASES TO SPINE 2 0.0006
306 SENSATION OF FOREIGN BODY 5 0.0006
307 COVID-19 104 0.0006
308 INTENTIONAL OVERDOSE 38 0.0006
309 DYSLIPIDAEMIA 3 0.0006
310 TREMOR 98 0.0006
311 CHOLECYSTITIS 7 0.0006
312 PRODUCT COLOUR ISSUE 3 0.0006
313 UPPER RESPIRATORY TRACT INFECTION 27 0.0006
314 ECCHYMOSIS 4 0.0006
315 GLOSSODYNIA 13 0.0006
316 PARANOIA 10 0.0006
317 SYNCOPE 58 0.0006
318 MICTURITION DISORDER 2 0.0006
319 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 41 0.0006
320 SWOLLEN TONGUE 18 0.0006
321 HYPOPNOEA 2 0.0006
322 ORAL DISCOMFORT 8 0.0006
323 FORMICATION 4 0.0006
324 EXTRASYSTOLES 4 0.0006
325 EAR PRURITUS 2 0.0006
326 EAR PAIN 11 0.0006
327 BONE EROSION 2 0.0006
328 MUSCLE TWITCHING 13 0.0006
329 COMPRESSION FRACTURE 3 0.0006
330 BRUXISM 3 0.0006
331 VISION BLURRED 76 0.0006
332 FAECES SOFT 4 0.0005
333 ALCOHOL USE 2 0.0005
334 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
335 LETHARGY 31 0.0005
336 HEART RATE ABNORMAL 3 0.0005
337 EYE SWELLING 20 0.0005
338 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 28 0.0005
339 SPEECH DISORDER 28 0.0005
340 FLANK PAIN 5 0.0005
341 EYE INFECTION 6 0.0005
342 HEART RATE IRREGULAR 12 0.0005
343 PERIORBITAL SWELLING 3 0.0005
344 PAROSMIA 4 0.0005
345 LACRIMATION INCREASED 16 0.0005
346 ADVERSE REACTION 7 0.0005
347 IMPAIRED DRIVING ABILITY 6 0.0005
348 DYSPHAGIA 50 0.0005
349 CARDIAC VALVE DISEASE 3 0.0005
350 BOWEL MOVEMENT IRREGULARITY 4 0.0005
351 EXERCISE TOLERANCE DECREASED 3 0.0005
352 GINGIVAL DISORDER 2 0.0005
353 THROAT TIGHTNESS 14 0.0005
354 RALES 3 0.0005
355 PANIC DISORDER 2 0.0005
356 SKIN WARM 3 0.0005
357 MUSCLE RUPTURE 2 0.0005
358 ORAL INFECTION 2 0.0005
359 PNEUMONIA FUNGAL 2 0.0005
360 OESOPHAGEAL PAIN 2 0.0005
361 LIGAMENT SPRAIN 5 0.0005
362 DYSPNOEA 285 0.0005
363 TRICUSPID VALVE INCOMPETENCE 4 0.0005
364 CONDITION AGGRAVATED 153 0.0005
365 CEREBRAL ATROPHY 2 0.0005
366 OBSTRUCTION 2 0.0005
367 SALIVARY HYPERSECRETION 5 0.0005
368 FOREIGN BODY 2 0.0005
369 PRODUCT PHYSICAL ISSUE 10 0.0005
370 MUSCLE DISORDER 4 0.0005
371 MUSCLE TIGHTNESS 8 0.0005
372 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0005
373 ORAL PAIN 11 0.0005
374 HYPERTENSION 104 0.0005
375 SMALL INTESTINAL OBSTRUCTION 6 0.0005
376 BALANCE DISORDER 42 0.0005
377 CONJUNCTIVITIS 9 0.0005
378 POOR VENOUS ACCESS 5 0.0005
379 THINKING ABNORMAL 9 0.0005
380 VIRAL INFECTION 16 0.0005
381 PRODUCT USE ISSUE 90 0.0005
382 DYSPHONIA 28 0.0005
383 NASOPHARYNGITIS 88 0.0005
384 ASTHENIA 178 0.0005
385 DEHYDRATION 63 0.0005
386 AORTIC VALVE INCOMPETENCE 2 0.0005
387 HYPOAESTHESIA 70 0.0005
388 BODY HEIGHT DECREASED 5 0.0005
389 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
390 FEELING COLD 13 0.0005
391 HERNIA 9 0.0005
392 ABNORMAL SENSATION IN EYE 2 0.0005
393 ERUCTATION 9 0.0005
394 HEADACHE 291 0.0005
395 CONTRAINDICATED PRODUCT ADMINISTERED 14 0.0005
396 HAEMORRHOIDS 9 0.0005
397 OSTEOPENIA 7 0.0005
398 VERTIGO 28 0.0005
399 PULMONARY THROMBOSIS 5 0.0005
400 IMMOBILE 2 0.0005
401 GASTRITIS 12 0.0005
402 HAEMORRHAGIC ANAEMIA 2 0.0005
403 ABDOMINAL ABSCESS 2 0.0005
404 PHYSICAL DISABILITY 2 0.0005
405 DENTAL CARIES 5 0.0005
406 EAR INFECTION 12 0.0005
407 GAIT INABILITY 15 0.0004
408 CHOLECYSTITIS CHRONIC 3 0.0004
409 ABASIA 11 0.0004
410 WRONG PRODUCT ADMINISTERED 3 0.0004
411 PRODUCT TASTE ABNORMAL 6 0.0004
412 URTICARIA 74 0.0004
413 HALLUCINATION, AUDITORY 7 0.0004
414 WRONG TECHNIQUE IN DRUG USAGE PROCESS 16 0.0004
415 LIP DRY 4 0.0004
416 PARAESTHESIA 69 0.0004
417 CHOLECYSTECTOMY 5 0.0004
418 GASTRIC DISORDER 15 0.0004
419 ABNORMAL DREAMS 12 0.0004
420 CHEST PAIN 80 0.0004
421 DIARRHOEA HAEMORRHAGIC 4 0.0004
422 OXYGEN SATURATION DECREASED 24 0.0004
423 SPINAL PAIN 5 0.0004
424 DISTURBANCE IN ATTENTION 23 0.0004
425 HEPATIC CIRRHOSIS 8 0.0004
426 LACERATION 4 0.0004
427 ARTERIOSCLEROSIS 4 0.0004
428 HOT FLUSH 32 0.0004
429 HAND FRACTURE 3 0.0004
430 JOINT INJURY 9 0.0004
431 PRODUCT PACKAGING ISSUE 4 0.0004
432 ENDOMETRIOSIS 2 0.0004
433 PARALYSIS 6 0.0004
434 DYSGEUSIA 31 0.0004
435 HYPERCHOLESTEROLAEMIA 4 0.0004
436 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
437 DISCOMFORT 25 0.0004
438 ORAL DISORDER 3 0.0004
439 MOUTH HAEMORRHAGE 3 0.0004
440 FEAR 11 0.0004
441 CYSTITIS 13 0.0004
442 POLLAKIURIA 17 0.0004
443 BLINDNESS TRANSIENT 3 0.0004
444 SENSITIVE SKIN 3 0.0004
445 HOSPICE CARE 4 0.0004
446 LIMB INJURY 11 0.0004
447 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
448 ARTHROPOD BITE 3 0.0004
449 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
450 THERAPEUTIC RESPONSE UNEXPECTED 18 0.0004
451 BLOOD POTASSIUM DECREASED 12 0.0004
452 HEART RATE DECREASED 14 0.0004
453 HAEMATOCHEZIA 22 0.0004
454 DYSARTHRIA 15 0.0004
455 POISONING 5 0.0004
456 FULL BLOOD COUNT DECREASED 8 0.0004
457 DYSPEPSIA 39 0.0004
458 TENDON PAIN 3 0.0004
459 ECONOMIC PROBLEM 6 0.0004
460 INFLUENZA 44 0.0004
461 TOOTH ABSCESS 4 0.0004
462 ACIDOSIS 3 0.0004
463 SLUGGISHNESS 4 0.0004
464 AMMONIA INCREASED 2 0.0004
465 DISSOCIATION 3 0.0004
466 BLOOD PRESSURE DECREASED 26 0.0004
467 RENAL FAILURE CHRONIC 3 0.0004
468 ENDOCARDITIS 2 0.0004
469 PAIN IN JAW 11 0.0004
470 PERIPHERAL VASCULAR DISORDER 2 0.0004
471 CONCUSSION 3 0.0004
472 FAILURE TO THRIVE 2 0.0004
473 HYPERSOMNIA 11 0.0004
474 INTENTIONAL DRUG MISUSE 8 0.0004
475 HYPERSENSITIVITY 71 0.0004
476 HEAD INJURY 12 0.0004
477 FURUNCLE 3 0.0004
478 RENAL PAIN 4 0.0004
479 FLUSHING 38 0.0004
480 IRRITABLE BOWEL SYNDROME 8 0.0004
481 SENSORY LOSS 3 0.0004
482 GASTROOESOPHAGEAL REFLUX DISEASE 30 0.0004
483 PHOTOPHOBIA 7 0.0004
484 URINARY INCONTINENCE 11 0.0004
485 NEPHROLITHIASIS 17 0.0004
486 PHARYNGITIS STREPTOCOCCAL 4 0.0004
487 FOOT FRACTURE 7 0.0004
488 BACK DISORDER 6 0.0004
489 DECUBITUS ULCER 3 0.0004
490 RESPIRATORY DISORDER 11 0.0004
491 ESCHERICHIA INFECTION 3 0.0004
492 NONSPECIFIC REACTION 2 0.0004
493 SEROTONIN SYNDROME 7 0.0004
494 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
495 TOOTH FRACTURE 4 0.0004
496 CYSTIC FIBROSIS 2 0.0004
497 MALAISE 158 0.0004
498 NERVE INJURY 4 0.0004
499 FATIGUE 280 0.0004
500 MITRAL VALVE INCOMPETENCE 4 0.0004
501 ABNORMAL BEHAVIOUR 14 0.0004
502 FACIAL PARALYSIS 3 0.0004
503 DERMATITIS CONTACT 4 0.0004
504 SCAB 4 0.0004
505 HAEMATURIA 12 0.0004
506 NEUROLOGICAL SYMPTOM 2 0.0003
507 PSEUDOMONAS INFECTION 3 0.0003
508 TINNITUS 16 0.0003
509 MUSCLE STRAIN 3 0.0003
510 MOUTH SWELLING 2 0.0003
511 DYSPNOEA EXERTIONAL 13 0.0003
512 HYPERVENTILATION 2 0.0003
513 ASTHMA 39 0.0003
514 DYSKINESIA 14 0.0003
515 EYELID OEDEMA 4 0.0003
516 BLOOD CALCIUM INCREASED 3 0.0003
517 NIGHT SWEATS 11 0.0003
518 RIB FRACTURE 7 0.0003
519 ATAXIA 4 0.0003
520 HYPERLIPIDAEMIA 4 0.0003
521 GAIT DISTURBANCE 64 0.0003
522 GASTROENTERITIS VIRAL 6 0.0003
523 PNEUMONIA 107 0.0003
524 INJECTION SITE VESICLES 2 0.0003
525 CONSTIPATION 72 0.0003
526 BONE DISORDER 6 0.0003
527 EXOSTOSIS 3 0.0003
528 URINARY TRACT INFECTION 56 0.0003
529 INSURANCE ISSUE 5 0.0003
530 AGITATION 24 0.0003
531 DRUG ABUSER 2 0.0003
532 UROSEPSIS 3 0.0003
533 NERVE COMPRESSION 3 0.0003
534 DIVERTICULITIS 9 0.0003
535 SPINAL OPERATION 4 0.0003
536 CHILLS 38 0.0003
537 SURGERY 19 0.0003
538 PIGMENTATION DISORDER 2 0.0003
539 TENDONITIS 5 0.0003
540 PHARYNGITIS 4 0.0003
541 HEPATIC STEATOSIS 6 0.0003
542 INFUSION SITE SWELLING 2 0.0003
543 FLATULENCE 18 0.0003
544 PHOTOPSIA 2 0.0003
545 RASH MACULAR 11 0.0003
546 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
547 ACUTE RESPIRATORY FAILURE 6 0.0003
548 AFFECT LABILITY 3 0.0003
549 LYMPHADENOPATHY 11 0.0003
550 ATELECTASIS 3 0.0003
551 INCOHERENT 2 0.0003
552 DIPLOPIA 8 0.0003
553 BRADYPHRENIA 2 0.0003
554 METASTASES TO BONE 5 0.0003
555 MIGRAINE 29 0.0003
556 ORAL CANDIDIASIS 4 0.0003
557 CORONAVIRUS INFECTION 2 0.0003
558 BLOOD PRESSURE ABNORMAL 6 0.0003
559 EYE PAIN 17 0.0003
560 SKIN DISORDER 10 0.0003
561 BREAST MASS 2 0.0003
562 BACK PAIN 69 0.0003
563 TASTE DISORDER 6 0.0003
564 RASH PRURITIC 16 0.0003
565 OCULAR HYPERAEMIA 14 0.0003
566 FLUID RETENTION 15 0.0003
567 IMPAIRED GASTRIC EMPTYING 4 0.0003
568 DEEP VEIN THROMBOSIS 19 0.0003
569 CONTUSION 28 0.0003
570 MUSCULOSKELETAL DISCOMFORT 5 0.0003
571 DROOLING 2 0.0003
572 MUSCLE SPASMS 53 0.0003
573 LARGE INTESTINE POLYP 2 0.0003
574 ORTHOSTATIC HYPOTENSION 5 0.0003
575 COORDINATION ABNORMAL 4 0.0003
576 TRANSFUSION 3 0.0003
577 NECK PAIN 16 0.0003
578 DEFAECATION URGENCY 2 0.0003
579 FALL 95 0.0003
580 PAPULE 2 0.0003
581 DUODENAL ULCER 2 0.0003
582 SLEEP DISORDER 20 0.0003
583 PRURITUS 108 0.0003
584 DRY EYE 14 0.0003
585 MOVEMENT DISORDER 9 0.0003
586 RED BLOOD CELL COUNT DECREASED 8 0.0003
587 BREAST CANCER METASTATIC 3 0.0003
588 GASTROINTESTINAL DISORDER 25 0.0003
589 AMNESIA 18 0.0003
590 SWELLING FACE 18 0.0003
591 HAEMATEMESIS 7 0.0003
592 RESTLESS LEGS SYNDROME 5 0.0003
593 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
594 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
595 CHOLELITHIASIS 9 0.0003
596 UNRESPONSIVE TO STIMULI 7 0.0003
597 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
598 MIDDLE INSOMNIA 5 0.0003
599 DEAFNESS 7 0.0003
600 SNEEZING 6 0.0003
601 ADVERSE DRUG REACTION 24 0.0003
602 BLOOD SODIUM DECREASED 5 0.0003
603 APHASIA 8 0.0003
604 HEPATOCELLULAR CARCINOMA 2 0.0003
605 AORTIC ANEURYSM 2 0.0003
606 DEVICE FAILURE 4 0.0003
607 CONVULSION 15 0.0003
608 THYROID DISORDER 4 0.0003
609 FREQUENT BOWEL MOVEMENTS 7 0.0003
610 FOOD ALLERGY 2 0.0003
611 CELLULITIS 13 0.0003
612 LUNG INFECTION 4 0.0003
613 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6 0.0003
614 PALLOR 7 0.0003
615 HYPOALBUMINAEMIA 2 0.0003
616 BASAL CELL CARCINOMA 4 0.0003
617 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
618 KIDNEY INFECTION 5 0.0003
619 HYPOTENSION 51 0.0003
620 PULMONARY EMBOLISM 24 0.0003
621 NASAL DISCOMFORT 2 0.0003
622 BLOOD ALBUMIN DECREASED 2 0.0003
623 MACULAR DEGENERATION 3 0.0003
624 OBESITY 4 0.0003
625 WOUND 7 0.0003
626 WRIST FRACTURE 3 0.0003
627 RASH 109 0.0002
628 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
629 BLOOD DISORDER 2 0.0002
630 LOCALISED INFECTION 6 0.0002
631 FIBROMYALGIA 6 0.0002
632 ABNORMAL FAECES 2 0.0002
633 HYPERAESTHESIA 2 0.0002
634 EYE DISORDER 8 0.0002
635 EYE IRRITATION 14 0.0002
636 EMBOLISM 2 0.0002
637 BLOOD UREA INCREASED 4 0.0002
638 ATRIAL SEPTAL DEFECT 2 0.0002
639 ABDOMINAL PAIN LOWER 6 0.0002
640 FACE OEDEMA 4 0.0002
641 CANDIDA INFECTION 4 0.0002
642 MUSCLE ATROPHY 3 0.0002
643 CATARACT 14 0.0002
644 PERIPHERAL SWELLING 36 0.0002
645 SCAR 4 0.0002
646 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
647 SKIN CANCER 5 0.0002
648 RASH GENERALISED 6 0.0002
649 NEUROPATHY PERIPHERAL 22 0.0002
650 NIGHTMARE 8 0.0002
651 CARDIAC MURMUR 2 0.0002
652 DELIRIUM 8 0.0002
653 PLEURAL EFFUSION 14 0.0002
654 HAEMORRHAGE 24 0.0002
655 BLOOD GLUCOSE DECREASED 11 0.0002
656 NAIL DISORDER 2 0.0002
657 INTENTIONAL PRODUCT MISUSE 20 0.0002
658 BEDRIDDEN 3 0.0002
659 INJURY 16 0.0002
660 TOOTH INFECTION 3 0.0002
661 HYPOXIA 8 0.0002
662 SARS-COV-2 TEST POSITIVE 3 0.0002
663 IMMUNOSUPPRESSION 2 0.0002
664 LUNG INFILTRATION 2 0.0002
665 MEMORY IMPAIRMENT 31 0.0002
666 EYE HAEMORRHAGE 3 0.0002
667 SWELLING 21 0.0002
668 CHROMATURIA 5 0.0002
669 BLINDNESS 9 0.0002
670 OPTIC NEURITIS 2 0.0002
671 PATHOGEN RESISTANCE 2 0.0002
672 UNDERDOSE 16 0.0002
673 OSTEOPOROSIS 9 0.0002
674 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
675 SKIN DISCOLOURATION 10 0.0002
676 INCREASED TENDENCY TO BRUISE 2 0.0002
677 HUNGER 3 0.0002
678 CARPAL TUNNEL SYNDROME 3 0.0002
679 ILL-DEFINED DISORDER 13 0.0002
680 DEVICE OCCLUSION 3 0.0002
681 OSTEOARTHRITIS 9 0.0002
682 BRONCHOSPASM 3 0.0002
683 FUNGAL INFECTION 7 0.0002
684 MUSCULOSKELETAL PAIN 11 0.0002
685 PRODUCT PRESCRIBING ERROR 5 0.0002
686 RASH ERYTHEMATOUS 10 0.0002
687 HERPES ZOSTER 12 0.0002
688 IMPAIRED QUALITY OF LIFE 3 0.0002
689 PULMONARY FIBROSIS 4 0.0002
690 POST PROCEDURAL COMPLICATION 4 0.0002
691 WEIGHT DECREASED 58 0.0002
692 PAIN IN EXTREMITY 61 0.0002
693 ANGER 7 0.0002
694 DECREASED APPETITE 48 0.0002
695 HYPOKINESIA 3 0.0002
696 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
697 MENTAL IMPAIRMENT 5 0.0002
698 NEURALGIA 5 0.0002
699 SKIN HAEMORRHAGE 3 0.0002
700 PULMONARY MASS 3 0.0002
701 ABDOMINAL DISTENSION 21 0.0002
702 PRESCRIBED UNDERDOSE 4 0.0002
703 AGGRESSION 10 0.0002
704 IRRITABILITY 12 0.0002
705 BRAIN INJURY 2 0.0002
706 ERYTHEMA 41 0.0002
707 CORONARY ARTERY DISEASE 6 0.0002
708 PRODUCT ADMINISTRATION ERROR 4 0.0002
709 MOTOR DYSFUNCTION 2 0.0002
710 DEVICE RELATED INFECTION 3 0.0002
711 LIMB DISCOMFORT 6 0.0002
712 VISUAL IMPAIRMENT 24 0.0002
713 CRYING 7 0.0002
714 PULMONARY HYPERTENSION 4 0.0002
715 PRODUCT QUALITY ISSUE 26 0.0002
716 CYANOSIS 3 0.0002
717 PAIN 117 0.0002
718 ANHEDONIA 5 0.0002
719 INJECTION SITE DISCOMFORT 2 0.0002
720 MOUTH ULCERATION 4 0.0002
721 JOINT DISLOCATION 2 0.0002
722 FULL BLOOD COUNT ABNORMAL 2 0.0002
723 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
724 HYPOTHYROIDISM 6 0.0002
725 EATING DISORDER 4 0.0002
726 PYREXIA 65 0.0002
727 BLOOD POTASSIUM INCREASED 3 0.0002
728 OEDEMA 10 0.0002
729 PNEUMONITIS 5 0.0002
730 OESOPHAGITIS 2 0.0002
731 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
732 MANIA 3 0.0002
733 JOINT SWELLING 22 0.0002
734 GASTROINTESTINAL PAIN 2 0.0002
735 DEPRESSION 41 0.0002
736 TACHYCARDIA 16 0.0002
737 TOOTH DISORDER 4 0.0002
738 URINARY RETENTION 6 0.0002
739 MALNUTRITION 2 0.0002
740 EYE PRURITUS 6 0.0002
741 RESPIRATORY FAILURE 13 0.0002
742 OCULAR DISCOMFORT 2 0.0002
743 BLISTER 10 0.0002
744 ARTHRITIS 14 0.0002
745 THERAPY NON-RESPONDER 8 0.0002
746 FISTULA 2 0.0002
747 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
748 ABDOMINAL PAIN 41 0.0002
749 INTERNAL HAEMORRHAGE 2 0.0002
750 ANGINA PECTORIS 5 0.0002
751 THROMBOSIS 14 0.0002
752 SHOCK 4 0.0002
753 GASTRIC HAEMORRHAGE 2 0.0002
754 LOCAL SWELLING 3 0.0002
755 DEVICE USE ISSUE 3 0.0002
756 HYPERKALAEMIA 6 0.0002
757 CARDIAC DISORDER 16 0.0002
758 MYALGIA 29 0.0002
759 LUNG NEOPLASM MALIGNANT 7 0.0002
760 LYMPHOCYTE COUNT DECREASED 3 0.0002
761 ACUTE MYOCARDIAL INFARCTION 5 0.0002
762 LABORATORY TEST ABNORMAL 5 0.0002
763 DRUG ERUPTION 3 0.0002
764 BLOOD IRON DECREASED 2 0.0002
765 BACTERAEMIA 2 0.0002
766 GALLBLADDER DISORDER 3 0.0002
767 MYOCLONUS 2 0.0002
768 ROAD TRAFFIC ACCIDENT 7 0.0002
769 GOUT 3 0.0002
770 MUSCULAR WEAKNESS 19 0.0002
771 BLOOD PRESSURE FLUCTUATION 4 0.0002
772 PRODUCT DOSE OMISSION ISSUE 49 0.0002
773 NOCTURIA 2 0.0002
774 BLOOD GLUCOSE INCREASED 31 0.0002
775 ATRIAL FIBRILLATION 16 0.0002
776 RECTAL HAEMORRHAGE 7 0.0002
777 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
778 HYPERCALCAEMIA 2 0.0002
779 ARTHROPATHY 9 0.0002
780 OSTEONECROSIS OF JAW 4 0.0002
781 FEMUR FRACTURE 5 0.0002
782 HAIR COLOUR CHANGES 2 0.0002
783 MUSCULOSKELETAL STIFFNESS 14 0.0002
784 DERMATITIS ALLERGIC 2 0.0002
785 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
786 INFLUENZA LIKE ILLNESS 13 0.0002
787 CHRONIC KIDNEY DISEASE 12 0.0002
788 GASTRIC ULCER 3 0.0002
789 INCREASED APPETITE 3 0.0002
790 HYPOPHAGIA 4 0.0002
791 OEDEMA PERIPHERAL 19 0.0002
792 ERECTILE DYSFUNCTION 4 0.0002
793 GENITAL HAEMORRHAGE 2 0.0002
794 ANOREXIA 2 0.0002
795 PRESCRIBED OVERDOSE 3 0.0002
796 SKIN ULCER 4 0.0002
797 HIATUS HERNIA 2 0.0002
798 HAEMATOMA 4 0.0002
799 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
800 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
801 PLATELET COUNT INCREASED 2 0.0002
802 IMMUNE SYSTEM DISORDER 2 0.0002
803 DISABILITY 3 0.0002
804 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
805 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
806 DEPRESSED MOOD 8 0.0002
807 HAEMATOCRIT DECREASED 3 0.0002
808 BLOOD CHOLESTEROL INCREASED 7 0.0002
809 MALIGNANT MELANOMA 2 0.0001
810 INTENTIONAL SELF-INJURY 3 0.0001
811 TYPE 2 DIABETES MELLITUS 5 0.0001
812 EXTRA DOSE ADMINISTERED 6 0.0001
813 FEEDING DISORDER 3 0.0001
814 ARRHYTHMIA 7 0.0001
815 BODY TEMPERATURE INCREASED 3 0.0001
816 DRUG TOXICITY 2 0.0001
817 ARTHRALGIA 61 0.0001
818 AKATHISIA 2 0.0001
819 HAEMOGLOBIN DECREASED 15 0.0001
820 PERIPHERAL COLDNESS 2 0.0001
821 RESPIRATORY ARREST 4 0.0001
822 INFECTION 21 0.0001
823 PROCEDURAL PAIN 4 0.0001
824 DERMATITIS 3 0.0001
825 PANCYTOPENIA 8 0.0001
826 DEMENTIA 4 0.0001
827 BLOOD TEST ABNORMAL 2 0.0001
828 LYMPHOPENIA 2 0.0001
829 IMPAIRED WORK ABILITY 3 0.0001
830 INCORRECT DOSE ADMINISTERED 32 0.0001
831 DRUG INTERACTION 22 0.0001
832 BLOOD CREATININE INCREASED 9 0.0001
833 DRUG EFFECT INCOMPLETE 5 0.0001
834 FLUID OVERLOAD 2 0.0001
835 GASTROENTERITIS 2 0.0001
836 INFLAMMATION 7 0.0001
837 INJECTION SITE MASS 5 0.0001
838 COLON CANCER 2 0.0001
839 IMMUNODEFICIENCY 2 0.0001
840 BLOOD COUNT ABNORMAL 2 0.0001
841 STOMATITIS 8 0.0001
842 COLITIS 5 0.0001
843 PRODUCT AVAILABILITY ISSUE 3 0.0001
844 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
845 DRUG ADMINISTRATION ERROR 4 0.0001
846 ADVERSE EVENT 12 0.0001
847 PERICARDIAL EFFUSION 3 0.0001
848 ANKLE FRACTURE 2 0.0001
849 EJECTION FRACTION DECREASED 2 0.0001
850 NERVOUS SYSTEM DISORDER 4 0.0001
851 MENINGIOMA 2 0.0001
852 TREATMENT NONCOMPLIANCE 7 0.0001
853 BONE DENSITY DECREASED 4 0.0001
854 PNEUMOTHORAX 2 0.0001
855 THERAPY INTERRUPTED 9 0.0001
856 MOOD SWINGS 4 0.0001
857 LUNG DISORDER 6 0.0001
858 IMPAIRED HEALING 4 0.0001
859 MULTIPLE FRACTURES 2 0.0001
860 PRODUCT SUBSTITUTION ISSUE 7 0.0001
861 SUICIDAL IDEATION 11 0.0001
862 PNEUMONIA ASPIRATION 3 0.0001
863 COAGULOPATHY 2 0.0001
864 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
865 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
866 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
867 CARDIOVASCULAR DISORDER 3 0.0001
868 SEDATION 3 0.0001
869 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
870 NEUROTOXICITY 2 0.0001
871 METASTASES TO LIVER 2 0.0001
872 PLATELET COUNT DECREASED 12 0.0001
873 SEIZURE 13 0.0001
874 CARDIAC FAILURE CONGESTIVE 9 0.0001
875 PULMONARY OEDEMA 5 0.0001
876 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
877 OSTEOMYELITIS 2 0.0001
878 HYPERGLYCAEMIA 4 0.0001
879 END STAGE RENAL DISEASE 2 0.0001
880 SKIN LESION 3 0.0001
881 EMOTIONAL DISTRESS 13 0.0001
882 BACTERIAL INFECTION 2 0.0001
883 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
884 TARDIVE DYSKINESIA 3 0.0001
885 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
886 MUSCULOSKELETAL DISORDER 2 0.0001
887 DIABETES MELLITUS 8 0.0001
888 NEOPLASM MALIGNANT 7 0.0001
889 GLAUCOMA 2 0.0001
890 LIVER FUNCTION TEST ABNORMAL 3 0.0001
891 WEIGHT INCREASED 23 0.0001
892 HEPATIC ENZYME INCREASED 7 0.0001
893 MENORRHAGIA 2 0.0001
894 PSYCHOTIC DISORDER 3 0.0001
895 SEPSIS 11 0.0001
896 NEUTROPHIL COUNT DECREASED 4 0.0001
897 EPILEPSY 3 0.0001
898 ACUTE KIDNEY INJURY 15 0.0001
899 HOSPITALISATION 15 0.0001
900 THERAPY CESSATION 5 0.0001
901 EMOTIONAL DISORDER 3 0.0001
902 CARDIAC ARREST 8 0.0001
903 PERITONITIS 2 0.0001
904 RENAL IMPAIRMENT 8 0.0001
905 OFF LABEL USE 82 0.0001
906 HIP FRACTURE 3 0.0001
907 LIVER FUNCTION TEST INCREASED 2 0.0001
908 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
909 SEPTIC SHOCK 4 0.0001
910 VISUAL ACUITY REDUCED 3 0.0001
911 MEDICATION ERROR 5 0.0001
912 DRY SKIN 12 0.0001
913 COLITIS ULCERATIVE 4 0.0001
914 HYPONATRAEMIA 5 0.0001
915 INJECTION SITE ERYTHEMA 11 0.0001
916 CEREBROVASCULAR ACCIDENT 15 0.0001
917 SKIN IRRITATION 4 0.0001
918 HYPOKALAEMIA 4 0.0001
919 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
920 DISEASE PROGRESSION 10 0.0001
921 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
922 CEREBRAL HAEMORRHAGE 3 0.0001
923 LIVER INJURY 2 0.0001
924 ALOPECIA 16 0.0001
925 INTESTINAL OBSTRUCTION 3 0.0001
926 HEPATITIS 2 0.0001
927 DEVICE ISSUE 7 0.0001
928 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
929 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
930 EXPOSURE VIA SKIN CONTACT 2 0.0001
931 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
932 MUCOSAL INFLAMMATION 2 0.0001
933 JOINT STIFFNESS 2 0.0001
934 DERMATITIS ATOPIC 4 0.0001
935 DRUG EFFECT DECREASED 4 0.0001
936 ANAEMIA 14 0.0001
937 MOOD ALTERED 2 0.0001
938 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
939 MENTAL STATUS CHANGES 2 0.0001
940 SKIN EXFOLIATION 6 0.0001
941 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
942 INTENTIONAL DOSE OMISSION 2 0.0001
943 HYPOACUSIS 3 0.0001
944 MOBILITY DECREASED 5 0.0001
945 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
946 DEVICE DISLOCATION 3 0.0001
947 NEEDLE ISSUE 2 0.0001
948 DRUG DEPENDENCE 11 0.0001
949 ASCITES 2 0.0001
950 RENAL FAILURE 9 0.0001
951 LIVER DISORDER 3 0.0001
952 DRUG DOSE OMISSION 11 0.0001
953 HEPATIC FAILURE 2 0.0001
954 ACNE 5 0.0001
955 DEATH 56 0.0001
956 EXPOSURE DURING PREGNANCY 4 0.0001
957 COGNITIVE DISORDER 3 0.0001
958 MULTIPLE SCLEROSIS 3 0.0001
959 METABOLIC ACIDOSIS 2 0.0001
960 HYPOGLYCAEMIA 3 0.0001
961 PRODUCT DOSE OMISSION 4 0.0001
962 INFUSION RELATED REACTION 4 0.0001
963 INJECTION SITE PRURITUS 4 0.0001
964 NEUTROPENIA 8 0.0001
965 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
966 DEVICE USE ERROR 2 0.0001
967 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
968 PANCREATITIS 3 0.0001
969 THROMBOCYTOPENIA 6 0.0001
970 PLASMA CELL MYELOMA 2 0.0001
971 BONE PAIN 3 0.0001
972 INJECTION SITE BRUISING 4 0.0001
973 CARDIAC FAILURE 4 0.0000
974 INJECTION SITE PAIN 15 0.0000
975 DEVICE LEAKAGE 2 0.0000
976 MENTAL DISORDER 2 0.0000
977 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
978 SKIN BURNING SENSATION 3 0.0000
979 MYOCARDIAL INFARCTION 7 0.0000
980 LEUKOPENIA 2 0.0000
981 INJECTION SITE SWELLING 3 0.0000
982 DRUG DOSE OMISSION BY DEVICE 3 0.0000
983 BRADYCARDIA 2 0.0000
984 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
985 INJECTION SITE HAEMORRHAGE 3 0.0000
986 RHEUMATOID ARTHRITIS 4 0.0000
987 DRUG INTOLERANCE 3 0.0000
988 DEVICE DIFFICULT TO USE 2 0.0000
989 FEBRILE NEUTROPENIA 2 0.0000
990 TOXICITY TO VARIOUS AGENTS 5 0.0000
991 DEVICE MALFUNCTION 2 0.0000
992 PSORIASIS 3 0.0000
993 BREAST CANCER 2 0.0000